
Lumexa Imaging fell 20.0% from $18.52 to $14.81, behind the S&P 500's +9.5%. Its worst day was Mar 26 (−29.8%), and its low came May 18 at $6.77.
Dec 11, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Lumexa Imaging closed at its highest level of the year, 0.1% above where the year started.
+0.1% · S&P 500 −1.1%
Lumexa Imaging shares rose 21.3%, while the S&P 500 fell 0.3%.
+21.3%, the year's best day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-0.20 missed the $0.05 estimate on $267.7M revenue (est. $263.2M); FY revenue guidance of $1.0B–$1.1B against the $1.1B consensus.
−29.8%, the year's worst day · S&P 500 −1.8%
EPS of $0.18 beat the $0.10 estimate on $252.5M revenue (est. $251.4M); FY revenue guidance of $1.0B–$1.1B against the $1.1B consensus.
−23.3% · S&P 500 +0.6%
Lumexa Imaging shares rose 14.4%, while the S&P 500 fell 0.7%.
+14.4% · S&P 500 −0.7%
EPS of $0.20 beat the $0.12 estimate on $264.2M revenue (est. $263.1M); FY revenue guidance of $1.0B–$1.1B against the $1.1B consensus.
+4.0% · S&P 500 +0.7%
EPS of $0.26 beat the $0.16 estimate on $272.0M revenue (est. $269.7M); FY revenue guidance of $1.0B–$1.1B against the $1.1B consensus.
+14.6% · S&P 500 +1.3%
Where it ended: a close of $14.81 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $0.16, revenue est. $269.6M).
Nothing in the past 12 months.
All LMRI dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LMRI and SPY from Benzinga historical bars. Not investment advice.